Mr. Prohaska has more than 19 years of experience in all aspects of preclinical drug development including the scientific, technical and operational aspects and on-site monitoring of non-GLP and GLP animal metabolism, pharmacokinetic, toxicology, genotoxicity, photosafety, safety pharmacology and carcinogenicity studies. In addition, he has managed the coordination of these studies with regulatory and clinical teams, including production of submission documents, due diligence activities, client consultation, data interpretation and client report preparation. Previously, he has worked for Furiex, PPD and Covance. After the purchase of Furiex Pharmaceuticals by Forest Laboratories (a subsidiary of Actavis plc), Mr. Prohaska formed his own consulting company, Protinus Consulting LLC. He received his Bachelor’s of Science in Biology at University of Wisconsin-Stevens Point.
Director, Preclinical Development